Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2015; 04(03): 150-151
DOI: 10.4103/2278-330X.173176
Letters to Editor

Changing trends in clinico-morphological profile of chronic myeloid leukemia-our experience

Anshu Palta
Department of Pathology and Medicine, Government Medical College and Hospital-32, Chandigarh, India
,
Pratibha Dhiman
Department of Pathology and Medicine, Government Medical College and Hospital-32, Chandigarh, India
,
Phiza Aggarwal
Department of Pathology and Medicine, Government Medical College and Hospital-32, Chandigarh, India
,
Monica Gupta
Department of Pathology and Medicine, Government Medical College and Hospital-32, Chandigarh, India
› Author Affiliations Source of Support: Nill.
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2015. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Two Years Report of Population Based Cancer Registries, 1999-2000. New Delhi: Indian Council of Medical Research, National Cancer Registry Programme; 2005.
  • 2 Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol 2002;19:141-50.
  • 3 Aziz Z, Iqbal J, Akram M, Saeed S. Treatment of chronic myeloid leukemia in the imatinib era: Perspective from a developing country. Cancer 2007;109:1138-45.
  • 4 Tardieu S, Brun-Strang C, Berthaud P, Michallet M, Guilhot F, Rousselot P, et al. Management of chronic myeloid leukemia in France: A multicentered cross-sectional study on 538 patients. Pharmacoepidemiol Drug Saf 2005;14:545-53.
  • 5 Cortes JE, Richard TS, Hagop K. Chronic myelogenous leukemia. In: Padzur R, Coia LR, Hoskins WJ, Wagman LD, editors. Cancer Management: a Multidisciplinary Approach. 10th ed. Lawrence: CMP Medica; 2007. p. 789.
  • 6 Ahmed R, Naqi N, Hussain I, Khattak BK, Nadeem M, Iqbal J. Presentating phases of chronic myeloid leukaemia. J Coll Physicians Surg Pak 2009;19:469-72.
  • 7 Malhotra P, Varma S. Chronic myeloid leukaemia in India. Lancet 2007;370:1127.